Table 4.
Clinical outcome after 3–6 months’ follow-up in relation to treatment strategies and neurological condition before treatment in 73 patients with a ruptured MCA aneurysm and an intraparenchymal hematoma
| Poor neurological condition, n (%) | Good neurological condition, n (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Total | Clinical outcome | Total | Clinical outcome | |||||
| mRS 0–3 | mRS 4–5 | mRS 6 | mRS 0–3 | mRS 4–5 | mRS 6 | |||
| 35 (48) | 6 (17)** | 8 (23) | 21 (60) | 38 (52) | 26 (68)** | 7 (18) | 5 (13) | |
| No treatment | 9 (26) | 0 | 0 | 9 (100) | 1 (3) | 1 (100) | 0 | 0 |
| Coiling | 10 (29) | 1 (10) | 5 (50) | 4 (40) | 17 (45) | 14 (82) | 3 (18) | 0 |
| No decompression | 0 | 0 | 0 | 0 | 10 (59) | 9 (90) | 1 (10) | 0 |
| Decompression† | 10 (100) | 1 (10) | 5 (50) | 4 (40) | 7 (41) | 5 (71) | 2 (29) | 0 |
| Clipping | 16 (46) | 5 (31) | 3 (19) | 8 (50) | 20 (53) | 11 (55) | 4 (20) | 5 (25) |
| No decompression | 2 (13) | 2 (25) | 0 | 0 | 6 (30) | 5 (83) | 0 | 1 (17) |
| Decompression† | 14 (87) | 3 (21) | 3 (21) | 8 (57) | 14 (70) | 6 (43) | 4 (29) | 4 (29) |
Data on pupil reactions on admission missing in three patients
mRS modified Rankin scale
**Significant difference (p < 0.01), also when only treated patients are analyzed (p < 0.01)
†With or without clot removal